Finally, based on its availability and solubility and after a preliminary study analyzing the effect on tumor cells’ viability, compound P14 (Figure 1B) was selected to biochemically study its interaction with KRAS, and to analyze putative effects on treated cancer cells’ signaling and viability. The gene discussed is KRAS; the disease is neoplasm.